Results 31 to 40 of about 6,813 (212)
Pathogenesis of chronic rhinosinusitis with nasal polyp and a prominent T2 endotype
Chronic rhinosinusitis is a heterogenous and multifactorial disease, characterized by persistent inflammation of the nose and paranasal sinuses, which causes nasal obstruction, nasal discharge, facial pain, and smell disturbance.
Said Ahmad Shah, Masayoshi Kobayashi
doaj +1 more source
Eosinophilic chronic rhinosinusitis (ECRS), which is a subgroup of chronic rhinosinusitis with nasal polyps, is characterized by eosinophilic airway inflammation extending across both the upper and lower airways.
Yoshiki Kobayashi +9 more
doaj +1 more source
Epigenetics of chronic rhinosinusitis and the role of the eosinophil [PDF]
AbstractBackground:One theory for the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) involves aberration in the expression of genes that maintain the sinonasal innate immune system. We propose that the alteration in gene expression seen in CRSwNP is a result of oxidative byproducts of eosinophils.
Kristin A, Seiberling +3 more
openaire +2 more sources
Background: Nowadays, the heterogeneity of chronic rhinosinusitis (CRS) has attracted extensive attention. The histological patterns and clinical characteristics may vary greatly in different areas and among different groups of people.
Xin Luo +9 more
doaj +1 more source
The SWI/SNF complex in eosinophilic and non eosinophilic chronic rhinosinusitis
Chronic rhinosinusitis (CRS) can be classified as eosinophilic (eCRS) or non-eosinophilic (neCRS) based on infiltration type. The SWI/SNF complex may be involved in the pathophysiology of CRS.To assess the expression of the SWI/SNF complex in both CRS groups; to correlate blood eosinophil count (BEC), and histopathology eosinophil count (HPEC) with the
Katarzyna Kowalik +6 more
openaire +4 more sources
Mepolizumab significantly reduces the number of annual exacerbations (AEs) and the maintenance dose of systemic corticosteroids (CSs) in patients with severe eosinophilic asthma (SEA).
Takanori Numata +9 more
doaj +1 more source
Treatments of refractory eosinophilic lung diseases with biologics
Biologics targeting the molecules associated with type 2 inflammation have significantly improved the outcomes of patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP).
Koichiro Asano +4 more
doaj +1 more source
This case reports the unique association of eosinophilic gastrointestinal disease with eosinophilic bronchitis, asthma and chronic rhinosinusitis and some features of lymphocytic hypereosinophilic syndrome, describes a diagnostic protocol for patients ...
Nair Parameswaran +5 more
doaj +1 more source
Gαi1/3 signaling mediates IL-5-induced eosinophil activation and type 2 inflammation in eosinophilic chronic rhinosinusitis [PDF]
Qingqing Jiao, Jiang Ji, Huanxia Xie
exaly +2 more sources
Introduction: Previous studies have reported a diverse range of threshold values for blood eosinophilia. In addition, a single predictive biomarker for eosinophilic chronic rhinosinusitis (CRS) with nasal polyps (ECRSwNP) has not yet been identified ...
Gian Luca Fadda MD +5 more
doaj +1 more source

